Accent Therapeutics, Inc.

Accent Therapeutics, Inc.

Accent Therapeutics, Inc.

Accent is developing oncology-focused, small molecule therapies targeting RNA-modifying proteins in the emerging field of epitranscriptomics.
Type
B2c
Raised
$103M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$63,000,000
Venture capital (Series B) - 2020
Atlas Venture EcoR1 Capital GV +5
$40,000,000
Venture capital (Series A) - 2018
Atlas Venture EcoR1 Capital The Column Group
Team Size
1–10
Employees
$63,000,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

Accent Therapeutics Completes $63M Series B Financing

$40,000,000 Venture capital (Series A)
Venture Funding News , MedCity News

Accent Therapeutics Launches with $40M Series A